ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

ACCC To Present Program On Impact Of New Technology

January 23, 1981

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

April 16, 2004